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Lack of AVNRT Induc t ion . Introduction: AV nodal reen(ran( tachycardia (AVNRT) is
not aiways rcproducibiy inducible. The purpose of this study was to determine the mechanisms
responsible for the lack of reproducible induction of AVNRT.
Methods and Results: The induction of AVNRT was assessed with atrial burst pacing, and
with atrial and ventricular programmed stimulation, each with one and two extrastimuli, in
103 patients with AVNRT. The stimulation protocol was repeated 10 times in the baseline
state, during isoproterenol infusion, and after atropine administration, or until AVNRT was
induced in 7 of 10 attempts. The mechanisms responsible for < 7 of 10 inductions were
classified as: (I) the inability to achieve critical AH prolongation; (2) fast pathway block; and
(3) slow pathway block. The induction endpoint was achieved in 90 patients: 55 in tbe baseline
state, 34 during isoproterenol infusion, and 1 after atropine. Tbe mechanism of noninducibility
in the baseline state (n = 48) was tbe inability to achieve a critical AH interval in 20%, fast
patbway block in 49%, and slow pathway block in 31% (I* = 0.02). During isoproterenol ad-
ministration (n = 14) and after atropine administration (n = 13), the three mechanisms were
equally responsible for nonreproducible induction of AVNRT.
Conclusions: The induction of AVNRT is poorly reproducible in approximately 10% of pa-
tients. In the baseline state, tbe most common reason for tbe inability to reproducibly induce
AVNRT is fast pathway block. In the presence of isoproterenol or atropine, each of the three
mechanisms was equally responsible for noninducibility of AVNRT. (J Cardiovusc Elearophxs-
iol. Vol. 7. pp. 494-502, June 1996}
tachycardia induction, reentry, arrhythmia mechanism
Introduction
Although AV nodal reentrant tachycardia
(AVNRT) is usually inducible by atrial or ven-
tricular pacing, sometimes it may not be repro-
ducibly inducible or may require isoproterenol or
atiopine administniiion for induction.'- No prior
study has quanlitated the mechanisms responsi-
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ble for the nonreprtxlucible induction of this ar-
rhythmia. Therefore, the purpose of this study was
to detennine the mechanisin(s) responsible for lack
of reproducible induction of AVNRT.
Methods
Patient Characteristics
The subjects of this study were 103 consecu-
tive patients (24 male and 79 female; mean age
55 ± 7 years) with paroxysmal supraventricular
tachycardia (PSVT) who underwent an electro-
physiologic test and were found to have typical
AVNRT. None of the patients had structural heart
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disease. The patients had been symptomatic from
AVNRT for 16 ± 12 months.
Electrophysiologic Testing
Electrophysiologic tests were performed in the
postabsorptive state after informed consent was
obtained and after all antiarrhythmic medications
had been discontinued for at least tive half-lives.
Three 7-French quadripolar electrodes were in-
serted in a femoral vein and positioned in the high
right atrium, across the tricuspid valve to record
the His-bundle electrogram, and in the right ven-
tricle. Leads V,. I, II. and III and the intracardiac
electrograms were displayed on an oscilloscope
and recorded on a Mingograf 7 recorder (Siemens-
Elema, Solna. Sweden). Pacing was performed
with a programmable simulator (Bloom Associ-
ates. Reading, PA. USA). The electrophysiologic
test was directed at inducing and detennining the
mechanism of PSVT, as well as mea-̂ uring the con-
duction properties and the refractory periods of the
AV node.' If the PSVT could not be provoked in
the baseline state, programmed stimulation was re-
peated during infusion of 2 /jg/min of isoproterenol.
Incremental pacing and programmed simulation
were performed from the right atrium and right
ventricle to define anterograde and retrograde AV
nodal conduction properties and refractoriness, and
to confirm that the provoked arrhythmia was in
fact AVNRT. Typical AVNRT was diagnosed us-
ing previously established criteria.^
AVNRT Induction Protocol
After the tachycardia was induced once and the
diagnosis of typical AVNRT was continned, pa-
tients underwent the investigational protocol, which
was approved by the University of Michigan Com-
mittee on Human Research. The stimulation pro-
tocol consisted of 18 steps (Table 1). Patients only
underwent the subsequent step of the induction
protocol if the previous one did not achieve the
endpoint of sustained AVNRT induction in at least
7 of 10 attempts. AVNRT that persisted for at least
30 seconds was defined as sustained. The first step
of the stimulation protocol used incremental
atrial pacing starting at 30 msec longer than the
AV block cycle length. One attempt was defined
as constant atriai pacing at 30 msec above the
AV block cycle length, then 20 msec above tbe
AV block cycle length, 10 msec above the AV
block cycle length, at the AV block cycle length,














































































A = atropine; B = baseline; I = isoproterenol; A2 = sin-
gle atrial extrastimulus; A2A.1 = double atrial extrastimuli;
V2 = single ventricular extra.stimulus: V2V3 = double
ventricular extrastimuli.
See text for complete description of pacing protocol.
length. During atrial pacing, the Sis were deliv-
ered until AH prolongation and subsequent AH
block occurred or, if AH block did not occur, for
at least 5 seconds. As with each step of the pro-
tocol, this was repeated 10 times. If the AVNRT
induction endpoint was not reached, the second
step of the protocol, programmed stitnulation of
the atria (Al) with a single premature atrial ex-
trastimulus {A2) was pertbrmed. A1A2 stitnula-
tion was pertbrmed with eight S1 s and with at least
two basic drive cycle lengths (6(X), 5{X), 400, 350
msec). The A1A2 coupling interval was decre-
mented in 10-msec steps until AVNRT was in-
duced or until the atrial or AV nodal refractory pe-
riod was reached. The third step consisted of pro-
grammed atrial stimulation with two extrastimuli
(A2A3). The third atrial extrastimulus was decre-
496 Journal of Cardiovascular Electrophysiology Vol. 7, No. 6, June 1996
merited in a manner similar to that described for
A2. The AiA2 coupling interval was selected to
be 10 to 30 msec longer than the fast pathway
effective refractory period. The fourth step used
fixed rate right ventricular pacing at 30. 20, and
10 msec above the VA block cycle length, at the
VA block cycle length, and at 10 msec shorter than
the VA block cycle length. One attempt wjis defined
in a manner similar to that described above in step
1 for fixed rate atrial pacing. Step 5 was pro-
grammed stimulation of the right ventricle with
one extrastimulus, and step 6 was with two ex-
trastimuli. When two ventricular extrasfimuli were
used, the V1V2 coupling interval was the short-
est coupling interval associated with VA conduc-
tion. When the endpoint of at least 7 of 10 suc-
cessful inductions of AVNRT was not achieved in
the baseline state witb steps 1 through 6, each step
was repeated during the infusion of 2 /jg/min of
intravenous isoproterenol infusion {steps 7 to 12).
If the endpoint was not achieved during isopro-
terenol administiation. the infusion was di.scontin-
ued. After at least 20 minutes, atropine (I mg) was
injected, and pacing steps 13 to 18 were performed
(Table I).
In accord with the selection criteria for this
study, all patients had AVNRT that could be pro-
voked at least once, allowing the diagnosis to be
established. However, in some patients, after the
diagnosis of AVNRT was established, the ar-
rhythmia could not be induced again despite per-
forming steps I through 18.
Mechanisms of Noninduction of AVNRT
The general mechanisms responsible for non-
inducibility of a reentrant tachycardia include the
inability to initiate reentry and the inability to main-
tain reentry. More specifically, when AVNRT could
not be reproducibly provoked, I of 3 mecha-
nisms for noninduction was identified. The first
mechanism, an example of the inability to initiate
reentry, was the inability to attain the critical atrial-
His (AH) interval required for induction of AVNRT.
This mechanism was determined to be responsi-
ble if the maximum AH during failed attempts to
induce AVNRT was shorter than the shortest AH
present when tachycardia was induced (Fig. 1).
The second possible mechanism was block in the
fast pathway. When manifest as a prolonged VA
block cycle length (> 350 msec), absent VA con-
duction,-* or critical AH prolongation without an
AV nodal echo, this would be another example
of failure to initiate reentry. When a few echoes
occurred and termination was due to retrograde
fast patbway block, this was an example of the in-
ability to maintain reentry (Fig. 2). The third pos-
sible mechanism was block in the slow pathway.
An AV block cycle length > 400 msec would pre-
vent tachycardia induction,^ while a retrograde AV
nodal echo(s) with subsequent anterograde slow
pathway block would prevent maintainanee of the
tachycardia (Fig. 3).
Statistical Analysis
Continuous variables are expressed as mean ±
1 SD and were compared using a /-test for paired
or unpaired variables. Chi-square analysis was used
to compare the frequencies of the mechanisms
responsible for inability to AVNRT. P values <
0.05 were considered statistically significant.
Results
Inducibility
The endpoint of AVNRT induction in at least
7 of 10 attempts was achieved in 90 of the 103
patients (Fig. 4). The number of AVNRT induc-
tions in the remaining 13 patients ranged from 0
to 6 (Fig. 4).
Mode of AVNRTInduction
Following the initial induction required to es-
tablish the diagnosis of the tachycardia, only steps
1, 2, 4, 7, 8, and 13 of the pacing protocol achieved
tbe endpoint of inducible AVNRT in at least 7 of
10 attempts (Fig. 5). This included 84 patients who
were inducibie with tixed rate atrial pacing (steps
1, 7, and 13), 5 who were induced witb atrial
programmed stimulation with a single atrial ex-
trastimulus (steps 2 and 8), and 1 patient in whom
burst ventrieular pacing (step 4) was effective.
Atrial programmed stimulation with two atrial ex-
trastimuli (steps 3, 9, and 15) and ventricular
programmed stimulation with one and two ex-
trastimuli (steps 5, 6, 11, 12, 17, and 18) did not
result in achievement of the endpoint in any pa-
tient.
Drug State During A VNRT Induction
Among the 90 patients in whom AVNRT was
induced in at least 7 of 10 attempts, after the ini-
tial induction required to establish the diagnosis of
the tachycardia, 55 had the endpoint reached in the










Figure 1. Inadequate AH prolongation preventing AVNRT induction. (A) The shortest AIA2 (310 msec) that conducts through
rhe A V node (A2H2 200 msec) is shown. (B) The subsequent AIA2 (300 msec) blocks in the A V node, demonstrating the effec-
tive refractnrx period of the AV node. The critical AH for induction of AVNRT was 290 msec in tbis patient. The drive train
stimuli (SI) and the alrial extrastimulus (S2) are shown. The tiirial depolarization that results from the S2 is labeled A2. Tlie
subsequent His-bundle depolarization is labeled H2. The figure is organized from lop lo bottom with lead III. the high right
atrial bipolar eleclrogram recording (HRA). the His-bundle bipolar electrogram recording (HBE). and the right ventricular
bipolar electrogram recording (RV).
baseline state, 34 during isoproterenol infusion,
and 1 after the administration of atropine. One pa-
tient who did not have inducible AVNRT in the
baseline state or during isoproterenol infusion did
not receive atropine because of a history of at-
ropine intolerance. There was no difference in
identifiable baseline clinical characteristics of pa-
tienus who attained the AVNRT induction endpoint
in the baseline state versus during drug adminis-
tration. However, tbere were several electrophys-
iologic characteristics that were different between
patients who achieved the induction endpoint in
the baseline state and those who did not (Table 2).
The electrophysiologic pitrameters of patients who
required isoproterenol to achieve the induction end-
point are shown in Table 3.
Mechanisms Responsible for Noninducihility of
AVNRT
After the initial induction of AVNRT to estab-
lish the diagnosis, the endpoint of 7 or more
AVNRT inductions out of 10 attempts was not
acbieved in 48 patients in the baseline state (Table
4). Among these 48 patients. 14 did not achieve
the endpoint during isoproterenol administration
and 12 did not achieve the endpoint after at-
ropine administration. Therefore, there were a to-
tal of 74 inducfion attempts that did not attain the
endpoint of at least seven inductions of AVNRT.
The mechanisms responsible for not achieving the
endpoint were tbe inability to attain a critical AH
interval in 22 patients (30%), failure of conduc-
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Figure 2. These recordings demonstrate fast pathway conduction block limiting the induction of A VNRT. (A) Anterograde fast
pathway conduction with an AIA2 of 370 m.sec and an A2H2 of 130 msec is shown. (B) An AIA2 of 360 msec is associated
with fast pathway conduction block and anterograde slow pathway conduction (A2H2 240 msec). Despite the jump, the tachy-
cardia is not induced due to retrograde fast pathway block-
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Figure 2. (Continued) (C) Critical prolongation of the AH interval i.s demonstrated. With fixed rate atrial pacing at 250 msec,
critical AH prolongation occurs (230 msec), the retrograde fast pathway is no longer refractory, ami the tachycardia is initi-
ated. The tracings and abbreviations are as described in Figure J, except lead II is also shown.
tion in the fast pathway in 27 patients (36%), and
failure of slow pathway conduction in the remaining
25 patients (34%). There was one patient in whom
two mechanisms were identified as the etiology of
noninduction in the baseline .state. Both of these
mechanisms were included in the analysis.
In the baseline state, there were 48 patients in
whom AVNRT was inducible in < 7 of 10 at-
tempts. The inability to achieve a critical AH in-
terval was the mechanism responsible in 20%, fast
pathway conduction block was responsible in 49%,
and slow pathway block was the mechanism re-
sponsible in 31% of the patients (P = 0.02). The
same mechanism was responsible Ior noninduc-
tion in each step of the protocol, except in one pa-
tient in whom the lack of induction during step 1
was due to the inability to achieve a critical AH
interval, while the mechanism in the remaining
steps during the baseline state was slow pathway
bkxrk. There was only one patient in whom step
4 (fixed rate ventricuhir pacing) resulted in achieve-
ment of the endpoint. In this patient, during atrial
pacing (steps I through 3). AVNRT induction was
limited by retrograde fast pathway block.
During isoproterenol admini.stration, only 14 of
the 48 patients (29%) in whom the induction
endpoint was not reached in the baseline state had
tachycardia that could not he reliably provoked. In
these 14 patients, the endpoint was not attained be-
cause of inability to achieve critical AH length-
ening in 6 patients (43%), fast pathway conduc-
tion block in 2 patients (14%), and slow pathway
conduction block in 6 patients (43%; P = NS).
Ajnong 13 patients in whom the endpoint was
not achieved in the baseline slate or during iso-
proterenol infusion, atropine administration resulted
in achievement of the induction endpoint in only
one patient. After atropine administration, inabil-
ity to adequately lengthen the AH interval, fast
pathway block, and slow pathway block were the
mechanisms responsihle for lack of AVNRT in-
duction in 6 patients (50%), 5 patients (42%), and
1 patient (8%; P = NS), respectively.
The mechanism responsible for lack of AVNRT
induction was the same with each step of the pro-
tocol for a particular dmg state. However, the nnech-
anism at times differed with the administration of
different drugs. For instance, in the 12 patients in
whom the tachycardia could never be induced at
least seven times, the mechanism resptmsible was
the same in each drug state in 6 patients: the in-
ability to achieve a critical AH interval in 3 pa-
tients, consistent fast pathway block in 1 patient,
and consistent slow pathway block in 2 patients
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Figure 3. Slow pathway conduction block that limits the induction of AVNRT. Note that A2 is associated with a long A2H2 in-
terval. A subsequent AV nodal echo (arrow) is due to retrograde fast pathway conduction. AVNRT induction is then prevented
by anterograde .slow pathway block. The tracings and abbreviations are as described in Figure I. except leads Vi. /. and II
are also shown.
were the mechanisms responsible in each dmg state
and during each step oi' ihe protocol. In the re-
maining 6 patients, fast pathway block was re-
sponsible in the baseline state in each patient, hut
in only I during i.soproterenol administration. The
isoproterenol had improved fast pathway conduc-
tion in the others, but slow pathway conduction
bkxrk occurred in 2, and inadequate AH prolon-
gation prevented reproducible AVNRT induction in
3. After atropine, slow pathway failure (n = 3) and
lack of adequate AH prolongation (n = 3) were re-
sponsible for the inability to induce AVNRT in at
least 7 of 10 attempts.
Four of the 103 patients in this study were di-
agnased with AVNRT, but the arrhythmia was never
provocable again. The mechanism responsible
for no further inductions of AVNRT in these 4 pa-
tients was consistent slow pathway conduction fail-
ure in 2 patients and consistent inadequate AH pro-
longation in 1 patient. In the remaining patient,
fast pathway conduction block limited induction
in the baseline state, but after isoproterenol and at-
ropine administration, inadequate AH prolongation
prevented tachycardia induction.
ITiere were also eight patients in whom the end-
point was met, but the tachycaidia was not induced
10 times. Seven of these 8 patients met the in-
duction endpoint in the baseline state, and one pa-
tient achieved the endpoint during isoproterenol
infusion. The mechanism responsible for < 10 in-
ductions was lack of critical AH prolongation in
2 patients and slow pathway conduction bk>ck in
5 patients. In the last patient, fast pathway con-
duction block limited induction in the baseline state




These results demonstrate that after the diag-












Figure 4. Percentage of patients (y axis) with 0 to 10 suc-
cessful AVNRT induction attempts, after the diagno.sis of
typical AVNRT was confirmed. Because the study endpoint
was seven or more inductions of AVNRT. patients who met
this endpoint were grouped together.
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Figure 5. Cumulative yield of AVNRT in seven or more at-
tempts at each step of the pacing protocol. For a complete
description of steps I through IH. see Table 1.
duced in at !ea.st 7 of 10 attempts in approximately
90% of patients with proven AVNRT if a variety
of pacing and drug interventions are utilized. Fast
pathway conduction failure is most commonly
responsible for inability to achieve the induction
endpoint in the baseline state, but with enhanced
adrenergic tone, is rarely the weak link. Approxi-
mately 99% of patients who meet this induction
endpoint will do so in the baseline state or after
isoproterenol infusion. Atropine administration is
rarely helpful when isoproterenol has not been help-
ful. Likewise, atrial pacing is the effective induc-
tion mode in over 90% of patients.
Autonomic Factors Affecting Noninducibility
The mechanism responsible for inability to
achieve the endpoint of 7 inductions of AVNRT
TABLE 2
Comparison of Baseline Electrophysiologic Characteristics
in Patients in Whom AVNRT was and was nol Inducible
in > 7 of 10 Aueiiipts in the Baseline State
































SCL = sinus cycle length; AH = atrial-His interval; HV
= His-ventricular interval; FP ERP = AV node fast
pathway effective refractory period; SP ERP = AV node
slow pathway effective refractory period; AVBCL =
atrioventricular block cycle length; VABCL = ventricular
atrial block cycle length; NS = no statistical difference.
TABLE 3
Electrophysiologic Characierisiics in 34 Patients with
AVNRT Induced During Isoproterenol AJiTiinistratinn





























Abbreviations as in Table 2.
out of 10 attempts in the baseline state was
most frequently fast pathway block. This im-
plies that the fast pathway is frequently the
weak link for induction in the baseline slate,
but fast pathway block is rarely responsible for
inability to achieve the induction endpoint dur-
ing autonomic stimulation. This observation
suggests that fast pathway conduction is more
marginal in the absence of sympathetic stimu-
lation than is slow pathway conduction. In-
ability to achieve adequate AH lengthening may
be easier to overcome with beta-blocker iher-
apy than with autonomic stimulation.^ Addi-
tionally, isoproterenol infusion could render the
tachycardia more difficult to induce, especially
if the fast pathway refractory period were to
become shorter than the slow pathway refrac-
tory period.
A previous study demonstrated that in the
absence of isoproterenol. the ventricular re-
sponse during atrial fibrillation slows after slow
pathway ablation for AVNRT/' However, re-
cent observations demonstrate that the ven-
tricular response increases when adrenergic
tone is enhanced with isoproterenol.^ This phe-
nomenom may also be due to the responsive-
ness of the fast pathway to adrenergic stimu-
lation.
I ABLE 4
Mechanisms Responsible lor Nonreprodtjcihle
Induction of AVNRT
Mechanism




















No T AH = inability to achieve criliciil AH prolongation;
FP = fast pathway; SP = slow pathway; NS = no statis-
tical difference.
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Previous Studies
In the present study, after isoproterenol admin-
istration, the induction endpoint wa.s still not
achieved in approximately one third of patients,
despite significantly improving anterograde and
retrograde conduction- Isoproterenol has previously
been shown to be beneficial for the induction of
AVNRT in patients with dual AV nodal physiol-
ogy, with iind without sustained reentry.' However,
a halance of anterograde slow pathway and retro-
grade fast pathway conduction is required for tachy-
cardia induction.''
Atropine was rarely helpful in inducing sus-
tained AVNRT for patients in whom isoproterenol
administiation did not cause reproducible AVNRT
induction. Atropine consistently improved AV and
VA conduction, yet this was not adequate to re-
prcxlucibly induce AVNRT. The results of a pre-
vious study suggested that atropine can be help-
ful at inducing AVNRT.- Because atropine improves
anterograde and retrograde conduction., it is not
surprising that atropine may aid in the induction
of AVNRT- In the present study, i.soprotet^nol ad-
ministration and atropine administration had sim-
ilar effects on AV and VA conduction. Perhaps this
is why atropine was rarely helpful in achieving the
induction endpoint after isoprotereno! had been in-
effective.
Limitations
The design of this study required that AVNRT
be inducible at least once for the patient to be in-
cluded in the study. There may be some patients
with AVNRT who are completely noninducihle,
and so these data may underestimate the true fre-
quency of nonreproducible induction of AVNRT.
An additional limitation of this study is that only
a single do.se of isoproterenol and atropine were
used. The results of this study may have been
different if other doses were used.
Clinical Implications
Some patients with documented PSVT are
completely noninducible, suggesting that their
tachycardia may be automatic atrial tachycardia.
However, the results of the present study sug-
gest that the diagnosis of AVNRT is still possi-
ble and should be entertained when dual AV
nodaJ physiology, with or without echties, is pres-
ent. In this instance, if prior medical therapy has
heen ineffective, empiric slow pathway ablation
may be a reasonable therapeutic option. Addi-
tionally, the lack of reproducibly inducible
AVNRT may lead to recurrences of AVNRT
after an apparently successful ablation proce-
dure, because lack of tachycardia induction may
be mistaken for a successful procedure. Finally.
AVNRT is often inducible with isoproterenol but
not in the baseline state. The.se data imply that
isoproterenol administration in conjunction with
programmed stimulation of the atria and ventri-
cles should be utilized to completely document
the lack of inducible AVNRT after slow path-
way ablation.**
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